arrow
A

Aaron G. Lim

University of Bristol
H指数:21
被引数:1,898

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementing sustainable liver health in Europe: a second EASL–Lancet Commission

在欧盟实施可持续肝脏健康:第二次EASL–Lancet委员会

2026-04-290
PRE
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data

撒哈拉以南非洲一般人群中丙型肝炎病毒的风险因素——系统综述数据分析

2025-10-010
OAAI
Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: A systematic review and meta-analysis

撒哈拉以南非洲普通人群中丙型肝炎病毒的患病率,趋势和分布: 系统回顾和荟萃分析

2024-09-135
OAAI
Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention Study
2023-11-014
OAAI
Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review

欧盟/欧洲经济区/英国国家普通人群和重点风险群体中乙型肝炎病毒流行率的估计:系统综述

2023-07-276
OAAI
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
2023-06-0128
OAAI
Trends in HIV incidence following scale-up of harm reduction interventions among people who inject drugs in Kachin, Myanmar, 2008-2020: analysis of a retrospective cohort dataset

2008-2020缅甸克钦地区注射吸毒者减少伤害干预措施扩大后的艾滋病毒发病率趋势: 回顾性队列数据集分析

2023-05-013
OAAI
Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial

在接受阿片类药物替代治疗的患者中,药房主导的与常规提供的丙型肝炎抗病毒治疗的成本效益: 一项实用集群随机试验的经济评估

2022-12-014
OAAI
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study

基于监狱的干预措施是在澳大利亚新南威尔士州注射吸毒者中消除HCV的关键: 一项建模研究

2022-11-147
OAAI